Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Individualised incretin-based treatment for type 2 diabetes.

× No keyword cloud information.

5 in total

1. SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.

Authors: Sindhu Rajan; Jacqueline Torres; Michael S Thompson; Louis H Philipson
Journal: Am J Physiol Endocrinol Metab Date: 2012-01-10 Impact factor: 4.310

2. A comprehensive review on the glucoregulatory properties of food-derived bioactive peptides.

Authors: Forough Jahandideh; Stephane L Bourque; Jianping Wu
Journal: Food Chem X Date: 2022-02-02

Review 3. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.

Authors: Juris J Meier
Journal: Nat Rev Endocrinol Date: 2012-09-04 Impact factor: 43.330

Review 4. Clinical application of glucagon-like Peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus.

Authors: Young Min Cho; Rhonda D Wideman; Timothy J Kieffer
Journal: Endocrinol Metab (Seoul) Date: 2013-12

5. Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.

Authors: Hsin-Chieh Tang; Calvin Yu-Chian Chen
Journal: Evid Based Complement Alternat Med Date: 2014-05-06 Impact factor: 2.629

5 in total